Department of Thoracic Surgery, Shanghai Tongji Hospital, School of Medicine, Tongji University, Xincun Rd. 389, Shanghai, 200065, People's Republic of China.
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Nutrition, Healthy
- Sponsor
- Shanghai Tongji Hospital, Tongji University School of Medicine
- Enrollment
- 150
- Primary Endpoint
- serum electrolytes
- Status
- Not yet recruiting
- Last Updated
- 3 years ago
Overview
Brief Summary
The coronavirus disease 2019 (COVID-19) pandemic has seriously threatened public health worldwide. Nutritional supplements may have a positive influence on the recovery of patients with viral infection. This study aimed to assess the influence of oral nutritional supplements (ONSs) on the biochemical parameters of elderly patients with mild-to-moderate COVID-19.
This clinical trial will be conducted on 145 elderly patients with mild-to-moderate COVID-19. Patients in the intervention group (n=74) received nutritional powder (vitamins, minerals, dietary fiber, polyphenols, omega-3, amino acids, and probiotics) for 14 days. Cases in the control group (n=71) took the placebo, except for nutritional powder, and they received the same treatment. Biochemical parameters were measured before and two weeks after intervention.
Detailed Description
The coronavirus disease 2019 (COVID-19) pandemic has seriously threatened public health worldwide. Nutritional supplements may have a positive influence on the recovery of patients with viral infection. This study aimed to assess the influence of oral nutritional supplements (ONSs) on the biochemical parameters of elderly patients with mild-to-moderate COVID-19. This clinical trial will be conducted on 145 elderly patients with mild-to-moderate COVID-19. Patients in the intervention group (n=74) received nutritional powder (vitamins, minerals, dietary fiber, polyphenols, omega-3, amino acids, and probiotics) for 14 days. Cases in the control group (n=71) took the placebo, except for nutritional powder, and they received the same treatment. Biochemical parameters were measured before and two weeks after intervention. After 14 days, patients in the groups will be measured by C-reactive protein (CRP), creatinine (Cr), blood urea nitrogen (BUN), and interleukin-8 (IL-8) ,white blood cell (WBC), red blood cell (RBC), platelet (PLT), neutrophil percentage (NE%), prothrombin time (PT), D-Dimer (DD), blood glucose, sodium (Na+), potassium (K+), aspartate aminotransferase (AST), glutamate pyruvic transaminase (ALT), albumin, calcium (Ca), arterial blood gas (ABG) parameters, and interleukin-10 (IL-10).
Investigators
Yongxin Zhou
Doctor
Shanghai Tongji Hospital, Tongji University School of Medicine
Eligibility Criteria
Inclusion Criteria
- •COVID-19-positive was confirmed by reverse transcription-polymerase chain reaction (RT-PCR);
- •Mild-to-moderate COVID-19 patients who aged 60-90 years old;
- •Consistency with the indication of enteral nutrition;
- •The time from diagnosis of COVID-19 to hospitalization was less than 24 h.
Exclusion Criteria
- •Oxygen saturation \< 93% or mechanical ventilation was required;
- •Systemic diseases (malignant tumors, autoimmune diseases, liver or kidney diseases);
- •Participation in other clinical trials within 3 months;
- •History of allergy to nutrients in the trial.
Outcomes
Primary Outcomes
serum electrolytes
Time Frame: 2 weeks
potassium (K+)(mmol/L)
ABG parameters
Time Frame: 2 weeks
oxygen partial pressure (PO2)(mmHg)
coagulation function and blood cell count (CBC)
Time Frame: 2 weeks
white blood cell (WBC) count(\*109/L)
kidney functions
Time Frame: 2 weeks
blood urea nitrogen (BUN)(mg/L)
inflammatory indices
Time Frame: 2 weeks
interleukin-8 (IL-8)(pg/mL)